Smad4 (DPC4) - A potent tumour suppressor?

British Journal of Cancer

Volumn 78, Issue 12, 1998, Pages 1615-1619

  Duff, E K ^a   Clarke, A R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cancer; DPC4; Smad4; Tumour suppressor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; COLORECTAL CANCER; HUMAN; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0031739638     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.731     Document Type: Article

References (52)

1. Armstrong JF, Kaufman MH, Harrison DJ and Clarke AR (1995) High frequency developmental abnormalities in p53-deficient mice. Curr Biol 5: 937-943
2. Arteaga CL, Dugger TC, Winnier AR and Forbes JT (1993) Evidence for a positive role of transforming growth factor-beta in human breast cancer cell tumorigenesis. J Cell Biochem 7: 87-193
3. Atfi A, Buisine M, Mazars A and Gespach C (1997) Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-β through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signalling pathway. J Biol Chem 272: 24731-24734
4. Attisano L, Carcamo J, Ventura F, Weis FMB, Massague J and Wrana JL (1993) Identification of human activin and TGF-beta type-I receptors that form heteromeric kinase complexes with type-II receptors. Cell 75: 671-680
5. Barrett MT, Schutte M, Kern SE and Reid BJ (1996) Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res 56: 4351-4353
6. Caestecker MP de, Hemmati P, Larisch-Bloch S, Ajmera R, Roberts AB and Lechleider RJ (1997) Characterisation of functional domains within Smad4/DPC4. J Biol Chem 272: 13690-13696
7. Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G and Whitman M (1997) Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389: 85-89
8. Clarke AR, Maandag ER, Vanroon M, Vanderlugt NMT, Vandervalk M, Hooper ML, Berns A and Riele HT (1992) Requirement for a functional Rb-1 gene in murine development. Nature 359: 328-330
9. Derynck R, Gelbart WM, Harland RM, Heldin CH, Kern SE, Massague J, Melton DA, Mlodzik MB, Padgett RW, Roberts AB, Smith J, Thomsen H, Vogelstein B and Wang XF (1996) Nomenclature vertebrate mediators of TGF-beta family signals. Cell 87: 173
10. Grau AM, Zhang L, Wang WX, Ruan SB, Evans DB, Abbruzzese JL, Zhang W and Chiao PJ (1997) Induction of p21(Wafl) expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer 57: 3929-3934
11. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, Dacosta LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE (1996a) DPC4, a candidate tumor-suppressor gene at human chromosome 18q21.1. Science 271: 350-353
12. Hahn SA, Hoque ATMS, Moskaluk CA, Dacosta LT, Schulte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hrunan RH and Kern SE (1996b) Homozygous deletion map at I8q21.1 in pancreatic cancer. Cancer Res 56: 490-494
13. Heldin CH, Miyazono K and ten Dijke P (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471
14. Hoque ATMS, Hahn SA, Schutte M and Kern SE (1997) DPC4 gene mutation in colitis associated neoplasia. Gut 40: 120-122
15. Ikezoe T, Takeuchi S, Kamioka M, Daibata M, Kubonishi I, Taguchi H and Miyoshi (1998) Analysis of the Smad2 gene in haematological malignancies. Leukemia 12: 94-95
16. Kim SK, Fan YH, Papadimitrakopoulou V, Clayman G, Hittelman WN, Hong WK, Lolan R and Mao L (1996) DPC4, a candidate tumor-suppressor gene, is altered infrequently in head and neck squamous-cell carcinoma. Cancer Res 56: 2519-2521
17. Kingsley DM (1994) The TGF-beta superfamily new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8: 133-146
18. Kong XT, Choi SH, Inoue A, Takita J, Yokota J, Kanada R, Yamamoto K, Bessho F, Yanagisawa M and Hayashi Y (1997) DPC4 gene mutation in colitis associated neoplasia. Eur J Cancer 33: 1962-1965
19. Knudson AG (1971) A statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823
20. Lagna G, Hata A, Hemmatibrivanlou A and Massague J (1996) Partnership between DPC4 and Smad proteins in TGF-beta signaling pathways. Nature 383: 832-836
21. Lei JY, Zou TT, Shi YQ, Zhou XI, Smolinski KN, Yin J, Souza RF, Appel R, Wang S. Cymes K, Chan O, Abraham JM, Harpaz N and Meltzer SJ (1996) Infrequent DPC-1 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. Oncogene 13: 2459-2462
22. Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM and Massague J (1996) Human MAD protein acting as a BMP-regulated transcriptional activator. Nature 381: 620-623
23. Liu F, Pouponnot C and Massague J (1997) Dual role of the Smad4/DPC4 tumor suppressor in TGF beta-inducible transcriptional complexes. Genes Dev 1: 3157-3167
24. Macgrogan D, Pegram M, Slamon D and Bookstein R (1997) Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene 15: 1111-1114
25. Maciassilva M, Abdollah S, Hoodless PA, Pirone R, Attisano L and Wrana JL (1996) MADR2 is a substrate of the TGF beta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 86: 1215-1224
26. Massague J, Attisano L, Carcamo J, Lopezeasillas F, Doody J, Wrana JF and Zentella A (1993) TGF-beta signals growth inhibition through a heteromeric kinase receptor. J Cell Biochem 17: 185
27. Moser AR, Pitot HC and Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324
28. Nagatake M, Takagi Y, Osada N, Uchida K, Mitsudomi T, Saji S, Shimokata K, Takahashi T and Takahashi T (1996) Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 56: 2718-2720
29. Piao Z, Kim H, Jeon BK, Lee WJ and Park C (1997) Relationship between loss of helerozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma. Cancer 80: 865-872
30. Polyak K (1996) Negative regulation of cell growth by TGF-beta. Biochim Biophys Acta - Rev Cancer 1242: 185-199
31. Pommier G (1992) Growth factors and intestinal neoplasms. Bull Cancer 79: 427-449
32. Powell SM, Harper JC, Hamilton SR, Robinson CR and Cummings OW (1997) Inactivation of Smad4 in gastric carcinomas. Cancer Res 57: 4221-4224
33. Riggins GJ, Thiagalingani S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JKY, Markowitz SD, Kinzler KW and Vogelstein B (1996) MAD-related genes in the human. Nature Genet 13: 347-349
34. Riggins GJ, Kinzler KW, Vogelstein B and Thiagalingam S (1997) Frequency of Smad gene mutations in human cancers. Cancer Res 57: 2578-2580
35. Ruzenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ and Kern SE (1997) Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 57: 1731-1734
36. Sah VP, Atardi LD, Mulligan DJ, Williams BO, Bronson RT and Jacks T (1995) A subset of p53-deficient embryos exhibit exencephaly. Nuture Genet 109: 175-180
37. Savage C, Das P, Fineli AL, Townsend SR, Sun CY, Baird SE and Padgett RW (1996) Caenorhabditid elegans genes Sma2, Sma-3, and Sma-4 define a conserved family of transforming growth factor-beta pathway components. Proc Natl Anal Sci USA 93: 790-794
38. Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero RA, Meltzer PS, Hahn SA and Kern SK (1996) DPC4 gene in various tumor types. Cancer Res 56: 2527-2530
39. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH and Gelbart WM (1995) Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139: 1347-1358
40. Shi YG, Hata A, Lo RS, Massague J and Pavletich NP (1997) A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388: 87-93
41. Sirard C, Delapompa JL, Elia A, Itie A, Mirtsos C, Cheung A, Hahn S, Wakeham A, Schwartz L, Kern SE, Rossant J and Mak TW (1998) The tumor suppressor gene Smad4/DPC4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev 12: 107-119
42. Takagi Y, Kohmura H, Futamura M, Kida H, Tanemura H, Shimokawa K and Saji S (1996) Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 111: 1369-1372
43. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin M and Taketo MM (1998) Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92: 645-656
44. Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Wilson JKV, Markowitz S, Hamilton SR, Kern SE, Kinzler KW and Vogelstein B (1996) Evaluation of candidate tumor-suppressor genes on chromosome 18 in colorectal cancers. Nature Genet 13: 343-346
45. Uchida K, Nagatake M, Osada H, Yatabe Y, Kondo M, Mitsudomi T, Masuda A, Takahashi T and Takahashi T (1996) Somatic in vivo alterations of the Js 18-I gene at 18q21 in human lung cancers. Cancer Res 56: 5583-5585
46. Verbeek W, Spirin K, Hatta Y, Miller C, Kawamata N, Takeuchi S, Koike M, Asou H, Simpson JF and Koeffler HP (1997) DPC4/Smad4 in non-pancreatic tumors with frequent LOH 18q21 and in hematological malignancies. Int J Oncol 10: 257-260
47. Waldrip WR, Bikoff EK, Hoodless PA, Wrana JL and Robertson EJ (1998) Smad2 signaling in extraembryonic tissues determines anterior posterior polarity of the early mouse embryo. Cell 92: 797-808
48. Watanabe T, Wang XL, Miyakawa A, Shiiba M, Imai Y, Sato T and Tanzawa H (1997) Mutational state of tumor suppressor genes (DCC, DPC4) and alteration on chromosome 18q21 in human oral cancer. Int J Oncol 11: 1287-1290
49. Wrana JL and Attisano L (1996) MAD-related proteins in TGF-beta signalling. Trends Genet 12: 493-496
50. Wrana JL, Carcamo J, Attisano L, Cheifetz S. Zentella A, Lopezcasillas F and Massague J (1992a) The type-11 TGF-beta receptor signals diverse responses in cooperation with the type-I receptor. CSH Symp Quant Biol 57: 81-86
51. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF and Massague J (1992b) TGF-beta signals through a heteromeric protein-kinase receptor complex. Cell 71: 1003-1014
52. Xin C, Rubock MJ and Whitman M (1996) A transcriptional partner for MAD proteins in TGF-beta signaling (vol. 383: 691, 1996). Nature 348: 648